Allogeneic HSCT for Symptomatic Female X-linked Chronic Granulomatous Disease Carriers
In conclusion, allogeneic HSCT may cure the phagocyte defect in symptomatic XL-CGD carriers and improve their recurrent and disabling infective and inflam matory symptoms but risks transplant-related complications.
Source: Journal of Clinical Immunology - Category: Allergy & Immunology Source Type: research
More News: Allergy & Immunology | Autoimmune Disease | Fungal Infections | Stem Cell Therapy | Stem Cells | Transplants